The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: Feasibility of CSF and plasma ctDNA in BRAF-altered glioma during treatment with plixorafenib.
 
Karisa Schreck
Honoraria - Novartis
Consulting or Advisory Role - Advarra; Nurix
Research Funding - Springworks Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - Fore Biotherapeutics
 
Grace Tobin
No Relationships to Disclose
 
Peng Huang
No Relationships to Disclose
 
Michaella Iacoboni
No Relationships to Disclose
 
Joy Fisher
No Relationships to Disclose
 
Chetan Bettegowda
Leadership - Belay Diagnostics; OrisDx
Stock and Other Ownership Interests - Belay Diagnostics; OrisDx
Consulting or Advisory Role - Haystack Oncology; Privo Technologies
Patents, Royalties, Other Intellectual Property - Belay Diagnostics (Inst); Haystack Oncology